|

Huaier Granule Clinical Trials

4 actively recruiting trials

Also known as: Z20000109#NMPA Approval Number#, Z20000109（NMPA Approval Number）

Pipeline

Phase 4: 3

Top Sponsors

  • Fudan University2
  • Xi'an Jiaotong University1
  • Liaoning Cancer Hospital & Institute1

Indications

  • Cancer4
  • Invasive Ductal Carcinoma, Breast1
  • Carcinoma Breast1
  • Pancreatic Cancer Resectable1
  • Triple Negative Breast Cancer1

Other4 trials

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4
Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Phase 4
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.